Tic Disorders, Tourette Syndrome, Study Group, International Parkinson and Movement Disorder Society

Tic Disorders and Tourette Syndrome Study Group

Christos_Ganos        Davide Martino

Christos Ganos       Davide Martino
Chair                             Chair

MDS Staff Liaison: Ken Buesing

Members

Donald L Gilbert
Mark Hallett
Andreas Hartmann
Andrea Lee
Irene Malaty
Pablo Mir
Kirsten Mueller-Vahl
Alexander Muenchau
Michael Okun
Tamara Pringsheim
Harini Sarva
David Shprecher
Harvey Singer
Marina AJ de Koning-Tijssen
Yulia Worbe

About the Tic Disorders and Tourette Syndrome Study Group

Background


Tourette syndrome (TS) and tic disorders are an important area in the movement disorders sub-specialty. The complexity of the phenomenological spectrum and disease mechanisms of tic disorders continues to present remarkable challenges to the community of clinicians, clinical scientists and basic neuroscientists. Although significant progress has been made, TS and tic disorders still lack homogeneity of recognition and pathway of care organization across the regions of the globe. Part of this depends on the lack of focus on these conditions within an international scientific community that welcomes clinicians and scientists across different disciplines from all over the world. Joining efforts to reach consensus on the core pathophysiological mechanisms of tic disorders, enhancing the identification of biomarkers that would have rapid clinical application, investigating efficacy and safety of novel treatment approaches, and accelerating the journey towards personalized treatment plans by improving patient selection and increasing access to established treatments, represent the key elements of our vision on how to advance this field. We believe that the international collaborative effort brought together within the Study Group on Tic disorders and TS would represent the most appropriate first step in this direction.

Goals/Mission/Main Objective(s)
 

  • To work towards a consensus on core disease mechanisms and discuss topical issues, steering the direction of future research.  

  • To identify markers of disease progression and improve phenotypic subtyping

  • To identify predictors and moderators of treatment response 

  • To increase international collaborative research efforts within the International Parkinson and Movement Disorder Society with regard to epidemiology, pathophysiology and treatment optimization

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice